First-in-human, dose escalation, phase I study of an antibody-based immunotherapy in patients with solid tumor
Tender information
DE_BKMSLeipzig, Germany
- Type
- tender
- Procedure
- Negotiated with prior publication of a call for competition / competitive with negotiation
- Ref. number
- 613395b4-40f4-4b45-b52b-6f9b70d2e729
- CPV
- 85145000
The contract to be awarded is for a CRO to conduct a multicenter, first-in-human Phase I dose-escalation study of an antibody-based immunotherapy in patients with solid tumors